{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:31:01Z","timestamp":1771669861556,"version":"3.50.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["No. ZR2024QH179"],"award-info":[{"award-number":["No. ZR2024QH179"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Medical and Health Technology Development Fund","award":["No. 202105010806"],"award-info":[{"award-number":["No. 202105010806"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01642-1","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T09:40:42Z","timestamp":1747215642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of melatonin in polycystic ovary syndrome: is there Hippo pathway crosstalk?"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5613-2382","authenticated-orcid":false,"given":"Lijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boda","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2718-7774","authenticated-orcid":false,"given":"Xinbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"issue":"3","key":"1642_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jama.2021.23769","volume":"327","author":"HG Huddleston","year":"2022","unstructured":"Huddleston HG, Dokras A. Diagnosis and treatment of polycystic ovary syndrome. JAMA. 2022;327(3):274\u20135.","journal-title":"JAMA"},{"key":"1642_CR2","doi-asserted-by":"publisher","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong C, Wu Y, Zhang L, Yu Y. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front Endocrinol (Lausanne). 2022;13:1091147.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1642_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/advances\/nmab141","volume":"13","author":"S Alesi","year":"2022","unstructured":"Alesi S, Ee C, Moran LJ, Rao V, Mousa A. Nutritional supplements and complementary therapies in polycystic ovary syndrome. Adv Nutr. 2022;13(4):1243\u201366.","journal-title":"Adv Nutr"},{"issue":"10","key":"1642_CR4","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.3390\/nu13103480","volume":"13","author":"C Vasey","year":"2021","unstructured":"Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: the role of melatonin. Nutrients. 2021;13(10):3480.","journal-title":"Nutrients"},{"issue":"6","key":"1642_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/biom13060943","volume":"13","author":"JA Boutin","year":"2023","unstructured":"Boutin JA, Kennaway DJ, Jockers R. Melatonin: facts, extrapolations and clinical trials. Biomolecules. 2023;13(6):943.","journal-title":"Biomolecules"},{"issue":"1","key":"1642_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13048-024-01450-z","volume":"17","author":"S Ziaei","year":"2024","unstructured":"Ziaei S, Hasani M, Malekahmadi M, Daneshzad E, Kadkhodazadeh K, Heshmati J. Effect of melatonin supplementation on cardiometabolic risk factors, oxidative stress and hormonal profile in PCOS patients: a systematic review and meta-analysis of randomized clinical trials. J Ovarian Res. 2024;17(1):138.","journal-title":"J Ovarian Res"},{"key":"1642_CR7","doi-asserted-by":"crossref","unstructured":"Lo Sardo F, Muti P, Blandino G, Strano S. Melatonin and Hippo pathway: is there existing Cross-Talk? Int J Mol Sci. 2017;18(9).","DOI":"10.3390\/ijms18091913"},{"issue":"6","key":"1642_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1210\/endrev\/bnac013","volume":"43","author":"KL Clark","year":"2022","unstructured":"Clark KL, George JW, Przygrodzka E, Plewes MR, Hua G, Wang C, Davis JS. Hippo signaling in the ovary: emerging roles in development, fertility, and disease. Endocr Rev. 2022;43(6):1074\u201396.","journal-title":"Endocr Rev"},{"issue":"1","key":"1642_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13048-023-01305-z","volume":"17","author":"Z Huang","year":"2024","unstructured":"Huang Z, Xu T, Liu C, Wu H, Weng L, Cai J, Liang N, Ge H. Correlation between ovarian follicular development and Hippo pathway in polycystic ovary syndrome. J Ovarian Res. 2024;17(1):14.","journal-title":"J Ovarian Res"},{"key":"1642_CR10","doi-asserted-by":"publisher","first-page":"3425877","DOI":"10.1155\/2022\/3425877","volume":"2022","author":"MK Qi","year":"2022","unstructured":"Qi MK, Sun TC, Yang LY, He JL, Guo YM, Wang HB, Wang HP. Therapeutic effect of melatonin in premature ovarian insufficiency: Hippo pathway is involved. Oxid Med Cell Longev. 2022;2022:3425877.","journal-title":"Oxid Med Cell Longev"},{"key":"1642_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"1642_CR12","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439\u201373.","journal-title":"J Assist Reprod Genet"},{"issue":"S7","key":"1642_CR13","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.5694\/mja18.00656","volume":"209","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Boyle JA, Garad RM, McAllister V, Downes L, et al. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the international Evidence-based guideline for the assessment and management of polycystic ovary syndrome. Med J Aust. 2018;209(S7):S3\u20138.","journal-title":"Med J Aust"},{"issue":"1","key":"1642_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6\u201315.","journal-title":"Fertil Steril"},{"key":"1642_CR15","doi-asserted-by":"publisher","first-page":"741764","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, et al. Resistance to the insulin and elevated level of Androgen: A major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:741764.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1642_CR16","doi-asserted-by":"publisher","first-page":"e230342","DOI":"10.1530\/JOE-23-0342","volume":"261","author":"J Yang","year":"2024","unstructured":"Yang J, Chen C. Hormonal changes in PCOS. J Endocrinol. 2024;261(1):e230342.","journal-title":"J Endocrinol"},{"issue":"8","key":"1642_CR17","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1642_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jpag.2014.01.104","volume":"27","author":"M Pawelczak","year":"2014","unstructured":"Pawelczak M, Rosenthal J, Milla S, Liu YH, Shah B. Evaluation of the pro-inflammatory cytokine tumor necrosis factor-\u03b1 in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2014;27(6):356\u20139.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"1642_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","volume":"95","author":"HF Escobar-Morreale","year":"2011","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, Gonz\u00e1lez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048\u201358. e1-2.","journal-title":"Fertil Steril"},{"issue":"3","key":"1642_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","volume":"303","author":"S Abraham Gnanadass","year":"2021","unstructured":"Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631\u201343.","journal-title":"Arch Gynecol Obstet"},{"key":"1642_CR21","doi-asserted-by":"publisher","first-page":"103155","DOI":"10.1016\/j.jri.2020.103155","volume":"141","author":"A Borthakur","year":"2020","unstructured":"Borthakur A, Valsala Gopalakrishnan YDP. Role of IL-6 signalling in polycystic ovarian syndrome associated inflammation. J Reprod Immunol. 2020;141:103155.","journal-title":"J Reprod Immunol"},{"key":"1642_CR22","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937.","journal-title":"Mol Metab"},{"issue":"5","key":"1642_CR23","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.fertnstert.2019.06.035","volume":"112","author":"JJ Kim","year":"2019","unstructured":"Kim JJ, Hwang KR, Oh SH, Chae SJ, Yoon SH, Choi YM. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values. Fertil Steril. 2019;112(5):959\u2013e661.","journal-title":"Fertil Steril"},{"issue":"2","key":"1642_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/ijms23020583","volume":"23","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. Polycystic ovary syndrome: A comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. 2022;23(2):583.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1642_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467\u2013520.","journal-title":"Endocr Rev"},{"key":"1642_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","volume":"92","author":"CJ Glueck","year":"2019","unstructured":"Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108\u201320.","journal-title":"Metabolism"},{"key":"1642_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1\u201313.","journal-title":"Clin Epidemiol"},{"issue":"5","key":"1642_CR28","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmv025","volume":"21","author":"N Naderpoor","year":"2015","unstructured":"Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21(5):560\u201374.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1642_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2265.2006.02693.x","volume":"66","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D. Effect of long-term Orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2007;66(1):103\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1642_CR30","first-page":"Cd010334","volume":"2015","author":"EJ van Zuuren","year":"2015","unstructured":"van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database Syst Rev. 2015;2015(4):Cd010334.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1642_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/humupd\/dmr042","volume":"18","author":"HF Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2012;18(2):146\u201370.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1642_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/NEJMoa1313517","volume":"371","author":"RS Legro","year":"2014","unstructured":"Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119\u201329.","journal-title":"N Engl J Med"},{"issue":"6","key":"1642_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","volume":"356","author":"RS Legro","year":"2007","unstructured":"Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, Metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356(6):551\u201366.","journal-title":"N Engl J Med"},{"issue":"3","key":"1642_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0015-0282(16)57408-1","volume":"63","author":"BW Donesky","year":"1995","unstructured":"Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril. 1995;63(3):439\u201363.","journal-title":"Fertil Steril"},{"key":"1642_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fendo.2019.00249","volume":"10","author":"D Zhao","year":"2019","unstructured":"Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z, Sharma R, et al. Melatonin synthesis and function: evolutionary history in animals and plants. Front Endocrinol (Lausanne). 2019;10:249.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1642_CR36","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","volume":"85","author":"N Wettschureck","year":"2005","unstructured":"Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev. 2005;85(4):1159\u2013204.","journal-title":"Physiol Rev"},{"issue":"7","key":"1642_CR37","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0092-8674(05)80056-X","volume":"71","author":"L Birnbaumer","year":"1992","unstructured":"Birnbaumer L. Receptor-to-effector signaling through G proteins: roles for beta gamma dimers as well as alpha subunits. Cell. 1992;71(7):1069\u201372.","journal-title":"Cell"},{"issue":"8","key":"1642_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/bies.201400017","volume":"36","author":"G Tosini","year":"2014","unstructured":"Tosini G, Owino S, Guillaume JL, Jockers R. Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease. BioEssays. 2014;36(8):778\u201387.","journal-title":"BioEssays"},{"issue":"18","key":"1642_CR39","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1111\/bph.13536","volume":"173","author":"R Jockers","year":"2016","unstructured":"Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, et al. Update on melatonin receptors: IUPHAR review 20. Br J Pharmacol. 2016;173(18):2702\u201325.","journal-title":"Br J Pharmacol"},{"key":"1642_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/bs.vh.2018.01.012","volume":"107","author":"F Otsuka","year":"2018","unstructured":"Otsuka F. Interaction of melatonin and BMP-6 in ovarian steroidogenesis. Vitam Horm. 2018;107:137\u201353.","journal-title":"Vitam Horm"},{"key":"1642_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fendo.2020.00085","volume":"11","author":"JM Olcese","year":"2020","unstructured":"Olcese JM. Melatonin and female reproduction: an expanding universe. Front Endocrinol (Lausanne). 2020;11:85.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1642_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1600-079X.2008.00602.x","volume":"46","author":"JT Kang","year":"2009","unstructured":"Kang JT, Koo OJ, Kwon DK, Park HJ, Jang G, Kang SK, et al. Effects of melatonin on in vitro maturation of Porcine oocyte and expression of melatonin receptor RNA in cumulus and granulosa cells. J Pineal Res. 2009;46(1):22\u20138.","journal-title":"J Pineal Res"},{"key":"1642_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0074-7696(08)61524-7","volume":"124","author":"AN Hirshfield","year":"1991","unstructured":"Hirshfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol. 1991;124:43\u2013101.","journal-title":"Int Rev Cytol"},{"issue":"2","key":"1642_CR44","first-page":"419","volume":"23","author":"B Gondos","year":"1970","unstructured":"Gondos B. Granulosa cell-germ cell relationship in the developing rabbit ovary. J Embryol Exp Morphol. 1970;23(2):419\u201326.","journal-title":"J Embryol Exp Morphol"},{"issue":"2","key":"1642_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1095\/biolreprod.104.039313","volume":"73","author":"P Amireault","year":"2005","unstructured":"Amireault P, Dub\u00e9 F. Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos. Biol Reprod. 2005;73(2):358\u201365.","journal-title":"Biol Reprod"},{"issue":"5","key":"1642_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/molehr\/5.5.402","volume":"5","author":"MT Itoh","year":"1999","unstructured":"Itoh MT, Ishizuka B, Kuribayashi Y, Amemiya A, Sumi Y. Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol Hum Reprod. 1999;5(5):402\u20138.","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"1642_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1095\/biolreprod.108.075655","volume":"81","author":"RJ Reiter","year":"2009","unstructured":"Reiter RJ, Tan DX, Manchester LC, Paredes SD, Mayo JC, Sainz RM. Melatonin and reproduction revisited. Biol Reprod. 2009;81(3):445\u201356.","journal-title":"Biol Reprod"},{"issue":"2\u20133","key":"1642_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.tox.2006.09.018","volume":"228","author":"I Adriaens","year":"2006","unstructured":"Adriaens I, Jacquet P, Cortvrindt R, Janssen K, Smitz J. Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis. Toxicology. 2006;228(2\u20133):333\u201343.","journal-title":"Toxicology"},{"issue":"3\u20134","key":"1642_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.anireprosci.2014.01.011","volume":"145","author":"MH Cruz","year":"2014","unstructured":"Cruz MH, Leal CL, da Cruz JF, Tan DX, Reiter RJ. Role of melatonin on production and preservation of gametes and embryos: a brief review. Anim Reprod Sci. 2014;145(3\u20134):150\u201360.","journal-title":"Anim Reprod Sci"},{"issue":"3","key":"1642_CR50","doi-asserted-by":"publisher","first-page":"e12550","DOI":"10.1111\/jpi.12550","volume":"66","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhang Z, Wang J, Lv D, Zhu T, Wang F, Tian X, Yao Y, Ji P, Liu G. Melatonin regulates the activities of ovary and delays the fertility decline in female animals via MT1\/AMPK pathway. J Pineal Res. 2019;66(3):e12550.","journal-title":"J Pineal Res"},{"issue":"1","key":"1642_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13287-019-1490-8","volume":"10","author":"B Huang","year":"2019","unstructured":"Huang B, Qian C, Ding C, Meng Q, Zou Q, Li H. Fetal liver mesenchymal stem cells restore ovarian function in premature ovarian insufficiency by targeting MT1. Stem Cell Res Ther. 2019;10(1):362.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"1642_CR52","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0015-0282(03)01008-2","volume":"80","author":"Y Nakamura","year":"2003","unstructured":"Nakamura Y, Tamura H, Takayama H, Kato H. Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production. Fertil Steril. 2003;80(4):1012\u20136.","journal-title":"Fertil Steril"},{"issue":"3","key":"1642_CR53","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1600-079X.2007.00524.x","volume":"44","author":"H Tamura","year":"2008","unstructured":"Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res. 2008;44(3):280\u20137.","journal-title":"J Pineal Res"},{"issue":"2","key":"1642_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/jpi.12026","volume":"54","author":"DX Tan","year":"2013","unstructured":"Tan DX, Manchester LC, Liu X, Rosales-Corral SA, Acuna-Castroviejo D, Reiter RJ. Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin\u2019s primary function and evolution in eukaryotes. J Pineal Res. 2013;54(2):127\u201338.","journal-title":"J Pineal Res"},{"issue":"16","key":"1642_CR55","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","volume":"71","author":"D Acu\u00f1a-Castroviejo","year":"2014","unstructured":"Acu\u00f1a-Castroviejo D, Escames G, Venegas C, D\u00edaz-Casado ME, Lima-Cabello E, L\u00f3pez LC, et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci. 2014;71(16):2997\u20133025.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1642_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1034\/j.1600-079X.2003.02111.x","volume":"34","author":"DX Tan","year":"2003","unstructured":"Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM, et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res. 2003;34(1):75\u20138.","journal-title":"J Pineal Res"},{"issue":"7","key":"1642_CR57","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.theriogenology.2014.07.011","volume":"82","author":"MH Cruz","year":"2014","unstructured":"Cruz MH, Leal CL, Cruz JF, Tan DX, Reiter RJ. Essential actions of melatonin in protecting the ovary from oxidative damage. Theriogenology. 2014;82(7):925\u201332.","journal-title":"Theriogenology"},{"issue":"4","key":"1642_CR58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1530\/REP-16-0641","volume":"153","author":"J Tong","year":"2017","unstructured":"Tong J, Sheng S, Sun Y, Li H, Li WP, Zhang C, et al. Melatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserve. Reproduction. 2017;153(4):443\u201351.","journal-title":"Reproduction"},{"issue":"5","key":"1642_CR59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/09513590.2017.1409713","volume":"34","author":"M Zheng","year":"2018","unstructured":"Zheng M, Tong J, Li WP, Chen ZJ, Zhang C. Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures. Gynecol Endocrinol. 2018;34(5):446\u201350.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"1642_CR60","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/0974-1208.126295","volume":"6","author":"P Jain","year":"2013","unstructured":"Jain P, Jain M, Haldar C, Singh TB, Jain S. Melatonin and its correlation with testosterone in polycystic ovarian syndrome. J Hum Reprod Sci. 2013;6(4):253\u20138.","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"1642_CR61","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0015-0282(01)01930-6","volume":"76","author":"R Luboshitzky","year":"2001","unstructured":"Luboshitzky R, Qupti G, Ishay A, Shen-Orr Z, Futerman B, Linn S. Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome. Fertil Steril. 2001;76(3):506\u201310.","journal-title":"Fertil Steril"},{"issue":"2","key":"1642_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2478\/folmed-2013-0012","volume":"55","author":"DD Terzieva","year":"2013","unstructured":"Terzieva DD, Orbetzova MM, Mitkov MD, Mateva NG. Serum melatonin in women with polycystic ovary syndrome. Folia Med (Plovdiv). 2013;55(2):10\u20135.","journal-title":"Folia Med (Plovdiv)"},{"key":"1642_CR63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.freeradbiomed.2018.11.027","volume":"131","author":"Y Fang","year":"2019","unstructured":"Fang Y, Zhang J, Li Y, Guo X, Li J, Zhong R, et al. Melatonin-induced demethylation of antioxidant genes increases antioxidant capacity through ROR\u03b1 in cumulus cells of prepubertal lambs. Free Radic Biol Med. 2019;131:173\u201383.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1642_CR64","first-page":"73","volume":"162","author":"F Xie","year":"2021","unstructured":"Xie F, Zhang J, Zhai M, Liu Y, Hu H, Yu Z, et al. Melatonin ameliorates ovarian dysfunction by regulating autophagy in PCOS via the PI3K-Akt pathway. Reproduction. 2021;162(1):73\u201382.","journal-title":"Reproduction"},{"issue":"1","key":"1642_CR65","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.1152\/ajpendo.00006.2020","volume":"319","author":"S Yi","year":"2020","unstructured":"Yi S, Zheng B, Zhu Y, Cai Y, Sun H, Zhou J. Melatonin ameliorates excessive PINK1\/Parkin-mediated mitophagy by enhancing SIRT1 expression in granulosa cells of PCOS. Am J Physiol Endocrinol Metab. 2020;319(1):E91\u2013101.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"1642_CR66","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13048-021-00912-y","volume":"14","author":"B Zheng","year":"2021","unstructured":"Zheng B, Meng J, Zhu Y, Ding M, Zhang Y, Zhou J. Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1\/Akt in granulosa cells of PCOS. J Ovarian Res. 2021;14(1):152.","journal-title":"J Ovarian Res"},{"issue":"1","key":"1642_CR67","doi-asserted-by":"publisher","first-page":"100594","DOI":"10.1016\/j.repbio.2021.100594","volume":"22","author":"R Guo","year":"2022","unstructured":"Guo R, Zheng H, Li Q, Qiu X, Zhang J, Cheng Z. Melatonin alleviates insulin resistance through the PI3K\/AKT signaling pathway in ovary granulosa cells of polycystic ovary syndrome. Reprod Biol. 2022;22(1):100594.","journal-title":"Reprod Biol"},{"key":"1642_CR68","doi-asserted-by":"publisher","first-page":"8218650","DOI":"10.1155\/2019\/8218650","volume":"2019","author":"K Yu","year":"2019","unstructured":"Yu K, Wang RX, Li MH, Sun TC, Zhou YW, Li YY, et al. Melatonin reduces androgen production and upregulates Heme Oxygenase-1 expression in granulosa cells from PCOS patients with hypoestrogenia and hyperandrogenia. Oxid Med Cell Longev. 2019;2019:8218650.","journal-title":"Oxid Med Cell Longev"},{"key":"1642_CR69","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.biopha.2017.05.035","volume":"92","author":"MM Rahman","year":"2017","unstructured":"Rahman MM, Kwon HS, Kim MJ, Go HK, Oak MH, Kim DH. Melatonin supplementation plus exercise behavior ameliorate insulin resistance, hypertension and fatigue in a rat model of type 2 diabetes mellitus. Biomed Pharmacother. 2017;92:606\u201314.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"1642_CR70","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/jphp.12297","volume":"66","author":"SA Pai","year":"2014","unstructured":"Pai SA, Majumdar AS. Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats. J Pharm Pharmacol. 2014;66(12):1710\u201321.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"1642_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13048-022-00946-w","volume":"15","author":"F Nikmard","year":"2022","unstructured":"Nikmard F, Hosseini E, Bakhtiyari M, Ashrafi M, Amidi F, Aflatoonian R. The boosting effects of melatonin on the expression of related genes to oocyte maturation and antioxidant pathways: a polycystic ovary syndrome- mouse model. J Ovarian Res. 2022;15(1):11.","journal-title":"J Ovarian Res"},{"issue":"4","key":"1642_CR72","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/asj.12675","volume":"88","author":"F Nikmard","year":"2017","unstructured":"Nikmard F, Hosseini E, Bakhtiyari M, Ashrafi M, Amidi F, Aflatoonian R. Effects of melatonin on oocyte maturation in PCOS mouse model. Anim Sci J. 2017;88(4):586\u201392.","journal-title":"Anim Sci J"},{"issue":"7","key":"1642_CR73","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3923\/pjbs.2018.340.347","volume":"21","author":"M Basheer","year":"2018","unstructured":"Basheer M, Rai S, Ghosh H, Ahmad Hajam Y. Therapeutic efficacy of melatonin against polycystic ovary syndrome (PCOS) induced by letrozole in Wistar rat. Pak J Biol Sci. 2018;21(7):340\u20137.","journal-title":"Pak J Biol Sci"},{"key":"1642_CR74","doi-asserted-by":"publisher","first-page":"119755","DOI":"10.1016\/j.lfs.2021.119755","volume":"281","author":"SR Hansda","year":"2021","unstructured":"Hansda SR, Haldar C. Uterine anomalies in cell proliferation, energy homeostasis and oxidative stress in PCOS hamsters, M. auratus: therapeutic potentials of melatonin. Life Sci. 2021;281:119755.","journal-title":"Life Sci"},{"key":"1642_CR75","doi-asserted-by":"publisher","first-page":"101585","DOI":"10.1016\/j.tice.2021.101585","volume":"73","author":"CM Seymen","year":"2021","unstructured":"Seymen CM, Yar Sa\u011flam AS, Elmazo\u011flu Z, Ar\u0131k GN, Take Kaplano\u011flu G. Involvement of endometrial IGF-1R\/IGF-1\/Bcl-2 pathways in experimental polycystic ovary syndrome: identification of the regulatory effect of melatonin. Tissue Cell. 2021;73:101585.","journal-title":"Tissue Cell"},{"key":"1642_CR76","doi-asserted-by":"crossref","unstructured":"Lombardi LA, Mattos LS, Sim\u00f5es RS, Florencio-Silva R, Sasso G, Carbonel AAF et al. Melatonin may prevent or reverse polycystic ovary syndrome in rats. Rev Assoc Med Bras (1992). 2019;65(7):1008-14.","DOI":"10.1590\/1806-9282.65.7.1008"},{"issue":"2","key":"1642_CR77","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1933719117711262","volume":"25","author":"V Tagliaferri","year":"2018","unstructured":"Tagliaferri V, Romualdi D, Scarinci E, Cicco S, Florio CD, Immediata V, et al. Melatonin treatment May be able to restore menstrual Cyclicity in women with PCOS: A pilot study. Reprod Sci. 2018;25(2):269\u201375.","journal-title":"Reprod Sci"},{"issue":"3","key":"1642_CR78","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12011-021-02725-y","volume":"200","author":"R Mousavi","year":"2022","unstructured":"Mousavi R, Alizadeh M, Asghari Jafarabadi M, Heidari L, Nikbakht R, Babaahmadi Rezaei H, et al. Effects of melatonin and\/or magnesium supplementation on biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, Double-Blind, Placebo-Controlled trial. Biol Trace Elem Res. 2022;200(3):1010\u20139.","journal-title":"Biol Trace Elem Res"},{"key":"1642_CR79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fendo.2019.00273","volume":"10","author":"M Jamilian","year":"2019","unstructured":"Jamilian M, Foroozanfard F, Mirhosseini N, Kavossian E, Aghadavod E, Bahmani F, et al. Effects of melatonin supplementation on hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2019;10:273.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1642_CR80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jad.2019.02.066","volume":"250","author":"A Shabani","year":"2019","unstructured":"Shabani A, Foroozanfard F, Kavossian E, Aghadavod E, Ostadmohammadi V, Reiter RJ, et al. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. J Affect Disord. 2019;250:51\u20136.","journal-title":"J Affect Disord"},{"issue":"3","key":"1642_CR81","first-page":"225","volume":"13","author":"F Mokhtari","year":"2019","unstructured":"Mokhtari F, Akbari Asbagh F, Azmoodeh O, Bakhtiyari M, Almasi-Hashiani A. Effects of melatonin administration on chemical pregnancy rates of polycystic ovary syndrome patients undergoing intrauterine insemination: A randomized clinical trial. Int J Fertil Steril. 2019;13(3):225\u20139.","journal-title":"Int J Fertil Steril"},{"issue":"1","key":"1642_CR82","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/09513590.2015.1101444","volume":"32","author":"A Pacchiarotti","year":"2016","unstructured":"Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecol Endocrinol. 2016;32(1):69\u201373.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1642_CR83","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12986-021-00586-9","volume":"18","author":"M Alizadeh","year":"2021","unstructured":"Alizadeh M, Karandish M, Asghari Jafarabadi M, Heidari L, Nikbakht R, Babaahmadi Rezaei H, et al. Metabolic and hormonal effects of melatonin and\/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Nutr Metab (Lond). 2021;18(1):57.","journal-title":"Nutr Metab (Lond)"},{"issue":"1","key":"1642_CR84","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/rmb2.12013","volume":"16","author":"M Kala","year":"2017","unstructured":"Kala M, Shaikh MV, Nivsarkar M. Equilibrium between anti-oxidants and reactive oxygen species: a requisite for oocyte development and maturation. Reprod Med Biol. 2017;16(1):28\u201335.","journal-title":"Reprod Med Biol"},{"key":"1642_CR85","doi-asserted-by":"crossref","unstructured":"He C, Wang J, Zhang Z, Yang M, Li Y, Tian X et al. Mitochondria Synthesize Melatonin to Ameliorate Its Function and Improve Mice Oocyte\u2019s Quality under in Vitro Conditions. Int J Mol Sci 2016;17(6).","DOI":"10.3390\/ijms17060939"},{"key":"1642_CR86","doi-asserted-by":"crossref","unstructured":"Reiter RJ, Tan DX, Rosales-Corral S, Galano A, Zhou XJ, Xu B. Mitochondria: Central Organelles for Melatonin\u2019s Antioxidant and Anti-Aging Actions. Molecules. 2018;23(2).","DOI":"10.3390\/molecules23020509"},{"issue":"1","key":"1642_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","volume":"36","author":"C Rodriguez","year":"2004","unstructured":"Rodriguez C, Mayo JC, Sainz RM, Antol\u00edn I, Herrera F, Mart\u00edn V, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004;36(1):1\u20139.","journal-title":"J Pineal Res"},{"issue":"3","key":"1642_CR88","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-0034-1371090","volume":"32","author":"M Maliqueo","year":"2014","unstructured":"Maliqueo M, Benrick A, Stener-Victorin E. Rodent models of polycystic ovary syndrome: phenotypic presentation, pathophysiology, and the effects of different interventions. Semin Reprod Med. 2014;32(3):183\u201393.","journal-title":"Semin Reprod Med"},{"issue":"10\u201312","key":"1642_CR89","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1387\/ijdb.120140ec","volume":"56","author":"E Collado-Fernandez","year":"2012","unstructured":"Collado-Fernandez E, Picton HM, Dumollard R. Metabolism throughout follicle and oocyte development in mammals. Int J Dev Biol. 2012;56(10\u201312):799\u2013808.","journal-title":"Int J Dev Biol"},{"issue":"5","key":"1642_CR90","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/humupd\/dmi020","volume":"11","author":"MK Skinner","year":"2005","unstructured":"Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update. 2005;11(5):461\u201371.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1642_CR91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.rbmo.2012.10.007","volume":"26","author":"MK Kim","year":"2013","unstructured":"Kim MK, Park EA, Kim HJ, Choi WY, Cho JH, Lee WS, et al. Does supplementation of in-vitro culture medium with melatonin improve IVF outcome in PCOS? Reprod Biomed Online. 2013;26(1):22\u20139.","journal-title":"Reprod Biomed Online"},{"key":"1642_CR92","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejogrb.2020.06.021","volume":"252","author":"S Karabulut","year":"2020","unstructured":"Karabulut S, Korkmaz O, Kutlu P, Gozel HE, Keskin I. Effects O follicular fluid oxidative status on human mural granulosa cells, oocyte competency and ICSI parameters. Eur J Obstet Gynecol Reprod Biol. 2020;252:127\u201336.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"1642_CR93","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130(6):1120\u201333.","journal-title":"Cell"},{"issue":"21","key":"1642_CR94","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact Inhibition and tissue growth control. Genes Dev. 2007;21(21):2747\u201361.","journal-title":"Genes Dev"},{"issue":"3","key":"1642_CR95","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrc2070","volume":"7","author":"K Harvey","year":"2007","unstructured":"Harvey K, Tapon N. The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nat Rev Cancer. 2007;7(3):182\u201391.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1642_CR96","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","volume":"122","author":"J Huang","year":"2005","unstructured":"Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating yorkie, the Drosophila homolog of YAP. Cell. 2005;122(3):421\u201334.","journal-title":"Cell"},{"issue":"10","key":"1642_CR97","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s10815-018-1235-0","volume":"35","author":"K Maas","year":"2018","unstructured":"Maas K, Mirabal S, Penzias A, Sweetnam PM, Eggan KC, Sakkas D. Hippo signaling in the ovary and polycystic ovarian syndrome. J Assist Reprod Genet. 2018;35(10):1763\u201371.","journal-title":"J Assist Reprod Genet"},{"key":"1642_CR98","doi-asserted-by":"publisher","first-page":"111524","DOI":"10.1016\/j.mce.2021.111524","volume":"541","author":"EC Dos Santos","year":"2022","unstructured":"Dos Santos EC, Lalonde-Larue A, Antoniazzi AQ, Barreta MH, Price CA, Dias Gon\u00e7alves PB, et al. YAP signaling in preovulatory granulosa cells is critical for the functioning of the EGF network during ovulation. Mol Cell Endocrinol. 2022;541:111524.","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"1642_CR99","doi-asserted-by":"publisher","first-page":"101454","DOI":"10.1016\/j.psj.2021.101454","volume":"100","author":"X Sun","year":"2021","unstructured":"Sun X, Niu X, Qin N, Shan X, Zhao J, Ma C, et al. Novel insights into the regulation of LATS2 kinase in prehierarchical follicle development via the Hippo pathway in Hen ovary. Poult Sci. 2021;100(12):101454.","journal-title":"Poult Sci"},{"key":"1642_CR100","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.gene.2018.08.018","volume":"678","author":"A Ai","year":"2018","unstructured":"Ai A, Xiong Y, Wu B, Lin J, Huang Y, Cao Y, et al. Induction of miR-15a expression by tripterygium glycosides caused premature ovarian failure by suppressing the Hippo-YAP\/TAZ signaling effector Lats1. Gene. 2018;678:155\u201363.","journal-title":"Gene"},{"issue":"43","key":"1642_CR101","doi-asserted-by":"publisher","first-page":"17474","DOI":"10.1073\/pnas.1312830110","volume":"110","author":"K Kawamura","year":"2013","unstructured":"Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A. 2013;110(43):17474\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1642_CR102","doi-asserted-by":"publisher","first-page":"e3000509","DOI":"10.1371\/journal.pbio.3000509","volume":"17","author":"N Borreguero-Mu\u00f1oz","year":"2019","unstructured":"Borreguero-Mu\u00f1oz N, Fletcher GC, Aguilar-Aragon M, Elbediwy A, Vincent-Mistiaen ZI, Thompson BJ. The Hippo pathway integrates PI3K-Akt signals with mechanical and Polarity cues to control tissue growth. PLoS Biol. 2019;17(10):e3000509.","journal-title":"PLoS Biol"},{"issue":"2","key":"1642_CR103","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ydbio.2011.07.003","volume":"357","author":"HJ Chen","year":"2011","unstructured":"Chen HJ, Wang CM, Wang TW, Liaw GJ, Hsu TH, Lin TH, et al. The Hippo pathway controls Polar cell fate through Notch signaling during Drosophila oogenesis. Dev Biol. 2011;357(2):370\u20139.","journal-title":"Dev Biol"},{"issue":"3","key":"1642_CR104","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.fertnstert.2020.07.031","volume":"114","author":"AJW Hsueh","year":"2020","unstructured":"Hsueh AJW, Kawamura K. Hippo signaling disruption and ovarian follicle activation in infertile patients. Fertil Steril. 2020;114(3):458\u201364.","journal-title":"Fertil Steril"},{"key":"1642_CR105","doi-asserted-by":"publisher","first-page":"702446","DOI":"10.3389\/fendo.2021.702446","volume":"12","author":"K Papageorgiou","year":"2021","unstructured":"Papageorgiou K, Mastora E, Zikopoulos A, Grigoriou ME, Georgiou I, Michaelidis TM. Interplay between mTOR and Hippo signaling in the ovary: clinical choice guidance between different gonadotropin preparations for better IVF. Front Endocrinol (Lausanne). 2021;12:702446.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1642_CR106","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/humupd\/dmt061","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, et al. Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2014;20(3):334\u201352.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1642_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2014-1020","volume":"36","author":"AJ Hsueh","year":"2015","unstructured":"Hsueh AJ, Kawamura K, Cheng Y, Fauser BC. Intraovarian control of early folliculogenesis. Endocr Rev. 2015;36(1):1\u201324.","journal-title":"Endocr Rev"},{"issue":"2","key":"1642_CR108","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","volume":"37","author":"PE Hughesdon","year":"1982","unstructured":"Hughesdon PE. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called hyperthecosis. Obstet Gynecol Surv. 1982;37(2):59\u201377.","journal-title":"Obstet Gynecol Surv"},{"issue":"10","key":"1642_CR109","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1096\/fj.201900609R","volume":"33","author":"M Tsoi","year":"2019","unstructured":"Tsoi M, Morin M, Rico C, Johnson RL, Paquet M, G\u00e9vry N, et al. Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance. Faseb J. 2019;33(10):10819\u201332.","journal-title":"Faseb J"},{"issue":"4","key":"1642_CR110","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jmedgenet-2011-100727","volume":"49","author":"T Li","year":"2012","unstructured":"Li T, Zhao H, Zhao X, Zhang B, Cui L, Shi Y, et al. Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome. J Med Genet. 2012;49(4):254\u20137.","journal-title":"J Med Genet"},{"issue":"2","key":"1642_CR111","doi-asserted-by":"publisher","first-page":"e5768","DOI":"10.1097\/MD.0000000000005768","volume":"96","author":"LL Jiang","year":"2017","unstructured":"Jiang LL, Xie JK, Cui JQ, Wei D, Yin BL, Zhang YN, et al. Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome. Med (Baltim). 2017;96(2):e5768.","journal-title":"Med (Baltim)"},{"issue":"1","key":"1642_CR112","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","volume":"43","author":"ZJ Chen","year":"2011","unstructured":"Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43(1):55\u20139.","journal-title":"Nat Genet"},{"issue":"12","key":"1642_CR113","doi-asserted-by":"publisher","first-page":"E2006","DOI":"10.1210\/jc.2013-2495","volume":"98","author":"YV Louwers","year":"2013","unstructured":"Louwers YV, Stolk L, Uitterlinden AG, Laven JS. Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(12):E2006\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1642_CR114","doi-asserted-by":"publisher","first-page":"10049","DOI":"10.1096\/fj.201900179RR","volume":"33","author":"X Lv","year":"2019","unstructured":"Lv X, He C, Huang C, Wang H, Hua G, Wang Z, et al. Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle development. Faseb J. 2019;33(9):10049\u201364.","journal-title":"Faseb J"},{"issue":"4","key":"1642_CR115","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1600-079X.2006.00371.x","volume":"41","author":"MJ Jarzynka","year":"2006","unstructured":"Jarzynka MJ, Passey DK, Ignatius PF, Melan MA, Radio NM, Jockers R, et al. Modulation of melatonin receptors and G-protein function by microtubules. J Pineal Res. 2006;41(4):324\u201336.","journal-title":"J Pineal Res"},{"issue":"3","key":"1642_CR116","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.pneurobio.2008.04.001","volume":"85","author":"SR Pandi-Perumal","year":"2008","unstructured":"Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol. 2008;85(3):335\u201353.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"1642_CR117","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15(2):73\u20139.","journal-title":"Nat Rev Cancer"},{"key":"1642_CR118","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2147\/CMAR.S230466","volume":"12","author":"L Mi","year":"2020","unstructured":"Mi L, Kuang H. Melatonin regulates cisplatin resistance and glucose metabolism through Hippo signaling in hepatocellular carcinoma cells. Cancer Manag Res. 2020;12:1863\u201374.","journal-title":"Cancer Manag Res"},{"key":"1642_CR119","doi-asserted-by":"crossref","unstructured":"Zhao X, Sun J, Su W, Shan H, Zhang B, Wang Y et al. Melatonin protects against lung fibrosis by regulating the Hippo\/YAP pathway. Int J Mol Sci. 2018;19(4).","DOI":"10.3390\/ijms19041118"},{"issue":"3","key":"1642_CR120","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1600-079X.2010.00795.x","volume":"49","author":"SY Shiu","year":"2010","unstructured":"Shiu SY, Pang B, Tam CW, Yao KM. Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of G\u03b1(s) and G\u03b1(q) proteins. J Pineal Res. 2010;49(3):301\u201311.","journal-title":"J Pineal Res"},{"issue":"4","key":"1642_CR121","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150(4):780\u201391.","journal-title":"Cell"},{"issue":"6","key":"1642_CR122","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrgastro.2016.59","volume":"13","author":"AW Hong","year":"2016","unstructured":"Hong AW, Meng Z, Guan KL. The Hippo pathway in intestinal regeneration and disease. Nat Rev Gastroenterol Hepatol. 2016;13(6):324\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1642_CR123","doi-asserted-by":"crossref","unstructured":"Luo J, Yu FX. GPCR-Hippo signaling in Cancer. Cells. 2019;8(5).","DOI":"10.3390\/cells8050426"},{"issue":"1","key":"1642_CR124","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-079X.2012.01026.x","volume":"54","author":"SY Shiu","year":"2013","unstructured":"Shiu SY, Leung WY, Tam CW, Liu VW, Yao KM. Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via Inhibition of constitutively active nuclear factor kappa B (NF-\u03baB): potential implications on prostate cancer chemoprevention and therapy. J Pineal Res. 2013;54(1):69\u201379.","journal-title":"J Pineal Res"},{"issue":"1","key":"1642_CR125","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jcp.22024","volume":"223","author":"HH Cho","year":"2010","unstructured":"Cho HH, Shin KK, Kim YJ, Song JS, Kim JM, Bae YC, et al. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol. 2010;223(1):168\u201377.","journal-title":"J Cell Physiol"},{"key":"1642_CR126","doi-asserted-by":"publisher","first-page":"3425877","DOI":"10.1155\/2022\/3425877","volume":"2022","author":"MK Qi","year":"2022","unstructured":"Qi MK, Sun TC, Yang LY, He JL, Guo YM, Wang HB, et al. Therapeutic effect of melatonin in premature ovarian insufficiency: Hippo pathway is involved. Oxid Med Cell Longev. 2022;2022:3425877.","journal-title":"Oxid Med Cell Longev"},{"key":"1642_CR127","doi-asserted-by":"crossref","unstructured":"Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022.","DOI":"10.1210\/endrev\/bnac001"},{"key":"1642_CR128","doi-asserted-by":"publisher","first-page":"116940","DOI":"10.1016\/j.lfs.2019.116940","volume":"236","author":"J Wang","year":"2019","unstructured":"Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940.","journal-title":"Life Sci"},{"issue":"2","key":"1642_CR129","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41574-018-0130-1","volume":"15","author":"A Karamitri","year":"2019","unstructured":"Karamitri A, Jockers R. Melatonin in type 2 diabetes mellitus and obesity. Nat Rev Endocrinol. 2019;15(2):105\u201325.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1642_CR130","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tem.2006.01.006","volume":"17","author":"S Gavi","year":"2006","unstructured":"Gavi S, Shumay E, Wang HY, Malbon CC. G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation. Trends Endocrinol Metab. 2006;17(2):48\u201354.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"1642_CR131","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ydbio.2012.05.008","volume":"367","author":"K Stra\u00dfburger","year":"2012","unstructured":"Stra\u00dfburger K, Tiebe M, Pinna F, Breuhahn K, Teleman AA. Insulin\/IGF signaling drives cell proliferation in part via Yorkie\/YAP. Dev Biol. 2012;367(2):187\u201396.","journal-title":"Dev Biol"},{"issue":"5","key":"1642_CR132","first-page":"996","volume":"6","author":"C Wang","year":"2016","unstructured":"Wang C, Jeong K, Jiang H, Guo W, Gu C, Lu Y, et al. YAP\/TAZ regulates the insulin signaling via IRS1\/2 in endometrial cancer. Am J Cancer Res. 2016;6(5):996\u20131010.","journal-title":"Am J Cancer Res"},{"issue":"7","key":"1642_CR133","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1158\/1541-7786.MCR-17-0023","volume":"15","author":"F Hao","year":"2017","unstructured":"Hao F, Xu Q, Zhao Y, Stevens JV, Young SH, Sinnett-Smith J, et al. Insulin receptor and GPCR crosstalk stimulates YAP via PI3K and PKD in pancreatic Cancer cells. Mol Cancer Res. 2017;15(7):929\u201341.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"1642_CR134","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.3390\/ijms14046981","volume":"14","author":"E Peschke","year":"2013","unstructured":"Peschke E, B\u00e4hr I, M\u00fchlbauer E. Melatonin and pancreatic Islets: interrelationships between melatonin, insulin and glucagon. Int J Mol Sci. 2013;14(4):6981\u20137015.","journal-title":"Int J Mol Sci"},{"key":"1642_CR135","doi-asserted-by":"crossref","unstructured":"Xu H, Bao X, Kong H, Yang J, Li Y, Sun Z. Melatonin protects against Cyclophosphamide-induced premature ovarian failure in rats. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221127430.","DOI":"10.1177\/09603271221127430"},{"issue":"3","key":"1642_CR136","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-079X.2007.00523.x","volume":"44","author":"RD Ramracheya","year":"2008","unstructured":"Ramracheya RD, Muller DS, Squires PE, Brereton H, Sugden D, Huang GC, et al. Function and expression of melatonin receptors on human pancreatic Islets. J Pineal Res. 2008;44(3):273\u20139.","journal-title":"J Pineal Res"},{"issue":"3","key":"1642_CR137","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1034\/j.1600-079X.2002.02903.x","volume":"33","author":"MC Picinato","year":"2002","unstructured":"Picinato MC, Haber EP, Cipolla-Neto J, Curi R, de Oliveira Carvalho CR, Carpinelli AR. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic Islets. J Pineal Res. 2002;33(3):156\u201360.","journal-title":"J Pineal Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01642-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01642-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01642-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T10:03:52Z","timestamp":1747217032000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01642-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1642"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01642-1","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have approved this submission and publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}